Why should you drink tea instead of coffee?
Drinking tea reduces non-cardiovascular mortality by 24%, reveals a study in 131 000 people presented…
31/08/2014 - 4 minutes
What’s new
Synpromics successfully use synthetic biology in plant science projects
Synpromics, a Scottish-based synthetic biology company today announced that it has successfully generated several highly…
27/08/2014 - 2 minutes
Adocia launches a Phase III in India for its Diabetic Foot Ulcer treatment
Adocia announced today the initiation of a clinical Phase III study in India of BioChaperone…
26/08/2014 - 3 minutes
KalVista start the clinical development of a new treatment for diabetic macular edema
KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces…
25/08/2014 - 3 minutes
When swimming supports science: Scienion contributes to the “Rheines Wasser” project with micro-array testing
Scienion today announced that the company supports the unique research project ‘Rheines Wasser’ involving a…
25/08/2014 - 3 minutes
The new strategy of Novartis to acquire Gamida Cell
The deal for the sale of Gamida Cell to Novartis is back on. Instead of a huge exit…
25/08/2014 - 2 minutes
Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease…
21/08/2014 - 2 minutes
Danish biotech Forward Pharma files for $200m IPO
Forward Pharma, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the…
20/08/2014 - 1 minute
uniQure acquires the gene therapy start-up InoCard
uniQure, a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an…
20/08/2014 - 3 minutes
Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel…
19/08/2014 - 2 minutes
GSK abandon its joint drug project with Galapagos
According to Reuters, Galapagos, a Belgian biotech group announced that GlaxoSmithKline has stopped a joint drug…
19/08/2014 - 2 minutes
Sanofi buy Mannkind’s inhaled insulin for $925m
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing…
19/08/2014 - 3 minutes
